[go: up one dir, main page]

WO2014162485A1 - Medical-information management system and medical-information management method - Google Patents

Medical-information management system and medical-information management method Download PDF

Info

Publication number
WO2014162485A1
WO2014162485A1 PCT/JP2013/059996 JP2013059996W WO2014162485A1 WO 2014162485 A1 WO2014162485 A1 WO 2014162485A1 JP 2013059996 W JP2013059996 W JP 2013059996W WO 2014162485 A1 WO2014162485 A1 WO 2014162485A1
Authority
WO
WIPO (PCT)
Prior art keywords
information
drug
combination
medical
medicine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2013/059996
Other languages
French (fr)
Japanese (ja)
Inventor
裕也 塔野岡
山田 和広
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Terumo Corp
Original Assignee
Terumo Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Terumo Corp filed Critical Terumo Corp
Priority to PCT/JP2013/059996 priority Critical patent/WO2014162485A1/en
Publication of WO2014162485A1 publication Critical patent/WO2014162485A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Images

Classifications

    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H70/00ICT specially adapted for the handling or processing of medical references
    • G16H70/40ICT specially adapted for the handling or processing of medical references relating to drugs, e.g. their side effects or intended usage

Definitions

  • the present invention relates to a medical information management system and a medical information management method for managing medical information such as drug information used in hospitals, for example.
  • Patent Document 1 Conventionally, in hospitals and the like, infusion pumps and the like have been used in order to appropriately administer drugs to patients (for example, Patent Document 1).
  • an object of the present invention is to provide a medical information management system and a medical information management method that can easily determine the suitability of a combination of medicines and reduce the burden on medical staff.
  • the object is to determine the suitability of combination administration information of a plurality of pieces of drug information administered to a subject using a plurality of medical devices, and the combination administration information of the plurality of pieces of drug information is inappropriate. Is achieved by a medical information management system characterized in that the drug combination inappropriate information is provided and the user is requested to re-input combination administration information of the plurality of drug information.
  • the user since it becomes the structure which asks a user to re-input the combination administration information of these several chemical
  • the drug combination inadequate information includes information on drugs that cannot be combined absolutely and information on drugs that cannot be combined in combination, and the user is provided with the information on drugs that cannot be combined as relative information that is not suitable for combination.
  • the combination administration information of the same plurality of pieces of drug information is re-input, the drug combination inappropriate information is not provided again.
  • the drug combination inadequate information includes information on drugs that cannot be combined absolutely and information on drugs that cannot be combined in combination.
  • the drug combination inappropriate information is not provided again. That is, the drug combination inadequate information includes “absolute combination impossible drug information” that should absolutely avoid the combination of drugs, and “relative combination” that should generally be avoided if possible. "Unavailable drug information”.
  • the “relative combination impossible drug information” is information that allows combination administration in some cases. Therefore, when the combination administration information of a plurality of pieces of drug information input by the user is “relative combination impossible drug information”, the fact is notified to the user, and the user recognizes the fact and the same. When the combination administration information of a plurality of drug information is input, the input is permitted. Therefore, the system is easy to use for the user.
  • the plurality of medical devices are arranged in a rack unit, and the rack unit is configured to be able to communicate with a medical information management device, and the medical information management device receives combination administration information of the plurality of drug information. It is obtained from the rack unit, based on the combination administration information of the obtained plurality of drug information, the suitability is determined, and when it is inappropriate, the drug combination inappropriate information is generated. To do.
  • the plurality of medical devices are arranged in a rack unit, and the rack unit is configured to be able to communicate with a medical information management device.
  • the medical information management device stores combination administration information of a plurality of drug information. Based on the combination administration information of the plurality of pieces of drug information acquired from the rack unit, the suitability is determined, and if it is inappropriate, the drug combination inappropriate information is generated. For this reason, even when a plurality of medicines are administered in combination using a plurality of medical devices and rack units, the medical information management device performs the suitability and smoothly transmits the results to the medical devices and rack units. In addition, it is possible to notify the user of inappropriate drug combination information.
  • the object is to determine the suitability of combination administration information of a plurality of pieces of drug information administered to a subject using a plurality of medical devices, and the combination administration information of the plurality of pieces of drug information is inappropriate. Is achieved by a medical information management method characterized in that the drug combination inappropriate information is provided and the user is requested to re-input combination administration information of the plurality of drug information.
  • a medical information management system and a medical information management method that can easily determine the suitability of a combination of medicines and reduce the burden on medical staff and the like are provided. be able to.
  • FIG. 5 is a schematic block diagram illustrating contents of a “first various information storage unit” in FIG. 4.
  • FIG. 5 is a schematic block diagram illustrating contents of a “first various information storage unit” in FIG. 4.
  • FIG. 5 is a schematic block diagram illustrating contents of a “first various information storage unit” in FIG. 4.
  • FIG. 5 is a schematic block diagram which shows the content of the "2nd various information storage part" of FIG. 3 is a schematic flowchart showing a main operation example of the “drug combination management system” shown in FIG. 1.
  • 6 is another schematic flowchart showing a main operation example of the “drug combination management system” shown in FIG. 1.
  • 6 is another schematic flowchart showing a main operation example of the “drug combination management system” shown in FIG. 1.
  • 6 is another schematic flowchart showing a main operation example of the “drug combination management system” shown in FIG. 1.
  • FIG. 1 is a schematic diagram showing a “drug combination management system 1” according to an embodiment of a “medical information management system” of the present invention.
  • the medicine combination management system 1 includes, for example, two infusion pumps 70a and 70b which are medical devices. These infusion pumps 70a and the like are, for example, for administering different drugs A and B to a subject, for example, a patient. That is, the infusion pump 70a and the like have a configuration in which a tube (not shown) that feeds a drug solution such as the drug A can be disposed therein, and performs operations such as pressing by pressing the tube. Thus, the flow rate of the chemical solution fed in the tube is controlled.
  • these three infusion pumps 70a and the like have, for example, a rack device 10 which is a rack portion shown in FIG.
  • the rack apparatus 10 has a rack body 11 and a communication box 15 for communicating with other devices at the lower part thereof.
  • the rack body 11 includes three mounting parts (first mounting part 12 and second mounting part) including two mounting parts for mounting two infusion pumps 70a and 70b as indicated by arrows in FIG. Part 13 and third attachment part 14). That is, the two infusion pumps 70a and 70b in FIG. 1 are arranged in the first mounting portion 12 and the second mounting portion 13, respectively.
  • the rack apparatus 10 shown in FIG. Has a configuration in which three infusion pumps can be arranged.
  • the medicine combination management system 1 includes, for example, a management server 30 that is a medical information management device, and the management server 30 is configured to be able to communicate with the rack device 10.
  • each infusion pump 70a. Etc. are configured to send liquids in cooperation via the rack device 10.
  • the infusion pump 70a and the like have an infusion pump side display 71 that is a display unit that displays various information, for example, and an infusion pump side input device 72 that is an input unit that inputs various information. Also have. Specifically, the infusion pump side input device 72 is a dial, an input button, or the like.
  • the rack apparatus 10 and the management server 30 such as the infusion pump 70a shown in FIG. 1 have a computer, and the computer includes a CPU (Central Processing Unit), a RAM (Random Access Memory), and a ROM (Read Only Memory). Etc., and these are connected via a bus.
  • a CPU Central Processing Unit
  • RAM Random Access Memory
  • ROM Read Only Memory
  • FIG. 2 is a schematic block diagram showing the infusion pump 70a and the like shown in FIG.
  • the infusion pump 70 a and the like have an “infusion pump control unit 73”.
  • the infusion pump control unit 73 controls the “infusion pump side input device 72” and the “infusion pump side display 71” shown in FIG. 1, and communicates with the “management server 30” in FIG. Side communication device 74 ".
  • the “infusion pump control unit 73” also controls each storage unit, determination unit (program), and the like shown in FIG. 2, and these configurations will be described later.
  • FIG. 3 is a schematic block diagram showing the rack apparatus 10 shown in FIG.
  • the rack apparatus 10 includes a “rack control unit 16”.
  • the “rack control unit 16” controls the “first mounting unit 12”, the “second mounting unit 13”, the “third mounting unit 14”, and the “communication box 15” shown in FIG.
  • the “rack-side communication device 18” that performs communication with the “rack-side display 17” to be displayed and the “management server 30” in FIG. 1 is controlled.
  • the “rack control unit 16” also controls each storage unit, processing unit (program), and the like shown in FIG. 3, and these configurations will be described later.
  • FIG. 4 is a schematic block diagram showing the management server 30 shown in FIG. As illustrated in FIG. 4, the management server 30 includes a “server control unit 31”.
  • the “server control unit 31” includes a “server-side input device 32” for inputting various information, a “server-side display 33” for displaying various information, and a “server-side communication device 34” for communicating with the rack device 10 of FIG. ”And“ first various storage units 40 ”and“ second various storage units 50 ”shown in FIG. 4 are also controlled.
  • 5 and 6 are schematic block diagrams showing the contents of “first various information storage unit 40” and “second various information storage unit 50” in FIG. 4, respectively. These contents will be described later.
  • FIGS. 7 to 10 are schematic flowcharts showing main operation examples of the “drug combination management system 1” shown in FIG.
  • the operation and the like will be described according to the flowcharts of FIGS. 7 to 10, and the configurations and the like of FIGS. 1 to 6 will be described.
  • a medical worker such as a nurse, who is a user, attaches the infusion pumps 70a and 70b to the rack apparatus 10 in FIG. 1, and the infusion pumps 70a and 70b control the liquid feeding, respectively.
  • the following describes an example in which data of the medicine A and the medicine B to be inputted are input to the patient simultaneously or successively.
  • step ST (hereinafter referred to as “ST”) 1 in FIG. 7, a nurse or the like controls the medicine A and medicine B with the infusion pumps 70 a and 70 b, respectively, and these are the same or continuous.
  • Information for administration in cooperation is input to the infusion pump 70a.
  • “medicine setting information drug name (drug name A, etc.), other infusion pump number (for example, 70b), etc.) to be linked” is input to the infusion pump 70a etc. To do.
  • the infusion pumps 70a and 70b associate the “medicine etc. setting information” input thereto with the infusion pump numbers (70a and 70b) of the infusion pumps 70a and 70b.
  • “setting information 75a” it is stored in the “pump side medicine setting information storage section 75”.
  • “infusion pump number 70a” is registered so as to deliver medicine A and cooperate (combine) with infusion pump 70b.
  • the infusion pump 70b in the figure also sends the medicine B and is registered so as to cooperate with the infusion pump 70a.
  • simultaneous administration is taken as an example. Therefore, in the present embodiment, the medicine A of the infusion pump 70a and the medicine B of the infusion pump 70b are administered simultaneously to the patient.
  • pump side medicine setting information 75a is an example of “combination administration information of a plurality of medicine information”.
  • the infusion pump 70a transmits the “pump side medicine setting information 75a” in the “pump side medicine setting information storage unit 75” of FIG.
  • the infusion pump 70b also transmits to the rack device 10 in the same manner.
  • the rack device 10 associates the “pump side medicine setting information 75a” received from each of the infusion pumps 70a and 70b with the rack number, for example, R001, as “rack side medicine etc. setting information 19a”.
  • the information is stored in the rack side medicine etc. setting information storage unit 19 ”(see FIG. 3). That is, as shown in “rack side medicine setting information 19a” in FIG. 3, the liquid feeding medicines A and B of the infusion pumps 70a and 70b related to the rack apparatus (R001) and their cooperation are stored in association with each other.
  • the “pump cooperation operation information presence / absence determination processing unit (program) 20” of FIG. 3 operates to determine whether or not “cooperation operation” information exists in the “rack side medicine setting information 19a”.
  • the rack apparatus 10 transmits the operation start information (infusion start) to the infusion pumps 70a and 70b, the infusion pumps 70a and 70b start to operate, and the infusion to the patient is started.
  • the management server 30 stores the received “rack side medicine setting information 19a” as “server side medicine etc. setting information” in the “server side medicine etc. setting information storage unit 41” of FIG.
  • the “combination impossible information determination processing unit (program) 42” in FIG. 5 operates, and “server side medicine etc. setting information storage unit 41” in FIG.
  • the “cooperative operation” information corresponding to “absolute combination impossible drug information” or “relative combination impossible drug information” is referred to as “server side drug etc. setting” with reference to “uncombinable drug information 43a” in the information storage unit 43. It is determined whether or not the information exists.
  • the “combination impossible information determination processing unit (program) 42” of FIG. 5 operates, and “absolute combination impossible drug information” or “relative combination impossible drug information” of “uncombinable drug information 43a” of FIG. It is determined whether or not the “cooperation operation” information corresponding to is present in the “server-side medicine etc. setting information”.
  • the management server 30 transmits the operation start information (infusion start) to the infusion pumps 70a and 70b via the rack device 10, and the infusion pumps 70a and 70b start to operate, and the infusion fluid is supplied to the patient. Is started.
  • the process proceeds to ST12. move on.
  • the “combination impossible information determination processing unit (program) 42” in FIG. 5 operates, and the cooperative operation information corresponding to “absolute combination impossible drug information” or “relative combination impossible drug information” is displayed as “uncombinable drug information”.
  • the information is stored in the “unmatchable medicine corresponding information storage unit 44” as “corresponding information”.
  • the “incompatibility drug applicable information” includes “infusion pump number (70a) of rack number (R001), drug (A), infusion pump number (70b), and“ cooperation ”of drug (B).
  • the “operation” corresponds to “relative combination impossible drug information” and is stored in the “uncombinable drug corresponding information storage unit 44”.
  • the management server 30 transmits the “uncombinable drug applicable information” in the “uncombinable drug applicable information storage unit 44” to the rack device 10, in this embodiment, for example, the rack number (R001).
  • the rack apparatus 10 transmits the received “uncombinable drug corresponding information” to the corresponding infusion pump 70a and infusion pump 70b.
  • the process proceeds to ST15.
  • the infusion pumps 70a and 70b in FIG. 1 display on the infusion pump-side display 71 or the like, for example, “cooperation operation” between the medicine A of the infusion pump number (70a) and the medicine B of the infusion pump number (70b).
  • the combination administration is displayed as “relative combination impossible drug information”, and a re-input screen is displayed. Therefore, a nurse or the like who has input information such as drug A to the infusion pump 70a or the like should generally avoid cooperation (combination) between drug A and drug B by the input if possible. It is possible to recognize that it is “relative combination impossible drug information”, and an opportunity to change the input is given.
  • ST16 it is determined on the re-input screen of the infusion pump-side display 71 etc. of the infusion pumps 70a and 70b whether or not the nurse or the like has re-entered the drug etc. setting information. That is, the “drug etc. setting information re-input determination unit (program) 76” of FIG. 2 is operated, and the “re-input screen” displayed on the infusion pump-side display 73 etc. It is determined whether or not “the other infusion pump number of the subject” has been re-input.
  • the process proceeds to ST17.
  • the “medicine etc. setting information re-input determination unit (program) 76” in FIG. 2 operates, and the re-input medicine etc. setting information is set as “pump side re-input medicine etc. setting information 77a” in FIG. It is stored in the side re-input medicine etc. setting information storage section 77 ”.
  • the infusion pump 70b is similarly processed.
  • the infusion pumps 70a and 70b transmit “pump-side re-input medicine setting information 77a” in the “pump-side re-input medicine setting information storage unit 77” to the rack device 10.
  • the rack apparatus 10 associates the “pump-side re-entry medicine setting information 77a” received from each of the infusion pumps 70a and 70b with the rack number (R001), and sets the “rack-side re-entry medicine etc. setting” of FIG. Information 21a ”is stored in the“ rack-side re-input medicine setting information storage unit 21 ”.
  • the rack apparatus 10 determines whether or not “cooperation operation” information exists in the “rack-side re-input medicine etc. setting information 21a”. That is, it is determined whether there is information on simultaneous or continuous administration of drugs using a plurality of infusion pumps 70a and the like.
  • the rack apparatus 10 transmits the operation start information (infusion start) to the infusion pumps 70a and 70b, the infusion pumps 70a and 70b start to operate, and the infusion to the patient is started.
  • operation start information infusion start
  • the management server 30 sets the received “rack-side re-entry medicine etc. setting information 21a” as “server-side re-entry medicine etc. setting information” and “the server-side re-entry medicine etc. setting information storage unit 51” in FIG. To remember.
  • ST24 the “medicine etc. setting information identity determination unit (program) 52” of the management server 30 of FIG. 6 operates, and the “server side reentry medicine etc. setting information storage unit 51” “server side reentry medicine etc. setting” The “information” is compared with “server-side medicine setting information” in the “server-side medicine setting information storage unit 41” in FIG.
  • the “medicine etc. setting information identity determination unit (program) 52” of FIG. 6 operates to judge whether “server side re-entry medicine etc. setting information” is the same as “server side medicine etc. setting information”. Is done. That is, whether or not a user such as a nurse has changed information such as a medicine setting (information on a medicine to be delivered and other linked infusion pump 80b etc.) on the re-input screen of the infusion pump 70a or the like. to decide.
  • a medicine setting information on a medicine to be delivered and other linked infusion pump 80b etc.
  • the management server 30 sets “server-side re-entry medicine setting information storage unit 51” “server-side re-entry medicine etc. setting information” and “combination impossible drug information storage unit 43” “combination impossible” in FIG. With reference to “drug information 43a”, it is determined whether or not “cooperative operation” information corresponding to “absolute combination drug information” or “relative drug combination information” exists.
  • the “absolute combination impossible drug information determination unit (program) 53” of FIG. 6 operates, and whether or not the “server side re-entry drug setting information” corresponds to “absolute combination impossible drug information”. Judging. That is, as in the present embodiment, the fact that the re-input information such as the nurse is not changed means that the doctor who dares to execute the combination (cooperation) with the medicine A and the medicine B It is determined whether the information corresponds to “absolute combination impossible drug information” for which simultaneous or continuous administration, which is a combination of drugs, should be avoided absolutely.
  • the management server 30 transmits the operation start information (infusion start) to the infusion pumps 70a and 70b via the rack device 10, and the infusion pumps 70a and 70b start to operate, and the infusion fluid to the patient. Is started.
  • the “relative combination impossible drug information” is information in which combination administration is permitted in some cases, and therefore, the same information is input by re-input.
  • “combinable drug information that cannot be combined” in consideration of the convenience of use by nurses and the like, it is configured to permit the delivery of medicine as input.
  • the present invention is not limited to the above-described embodiment.
  • the infusion pump 70a and the like have been described as an example of the medical device, but the present invention is not limited to this, and can be suitably applied to other medical devices such as a syringe pump.
  • whether or not it corresponds to “uncombinable drug information 43a” or the like is executed by the management server 30 via the rack device 10, but the present invention is not limited to this and is not limited to this.
  • Such a determination may be made by the pump 70a, the rack device 10, or the like.
  • the editing of “uncombinable drug information 43a” in the “uncombinable drug information storage unit 43” is not referred to deeply.
  • a nurse or the like will create a database manually.
  • the present invention is not limited to this.
  • drug information that cannot be combined from the “Nichi medicine combination contraindication database” provided by the Japan Medical Association may be incorporated into the “non-combination drug information storage unit 43” and converted into a database.
  • the database may be edited for each hospital. In other words, the editing of the “uncombinable drug information 43a” in the “uncombinable drug information storage unit 43” is not limited to manual input by a nurse or the like, but the “uncombinable drug information 43a” is acquired by communication with the outside. Is possible.
  • DESCRIPTION OF SYMBOLS 1 Drug combination management system, 10 ... Rack apparatus, 11 ... Rack main body, 12 ... 1st mounting part, 13 ... 2nd mounting part, 14 ... 3rd mounting part, DESCRIPTION OF SYMBOLS 15 ... Communication box, 16 ... Rack control part, 17 ... Rack side display, 18 ... Rack side communication apparatus, 19 ... Rack side chemical
  • Server side input device 33 ... Server side display, 34 ... Server side communication apparatus, 40 ... 1st various memory
  • storage part 41... Server side medicine setting information Memory unit 42... Combination impossible information determination processing unit (program) 43... Combination impossible drug information storage unit 43 a... Combination impossible drug information 44. ... 2nd various information storage part, 51 ... Server side re-entry medicine etc. setting information storage part, 52 ... Medicine etc. setting information identity judgment part (program), 53 ... Absolute combination impossible medicine Information judging unit (program), 70a, 70b ... infusion pump, 71 ... infusion pump side display, 72 ... infusion pump side input device, 73 ... infusion pump control unit, 74 ... infusion pump Side communication device, 75...
  • Pump side medicine setting information storage section 75 a... Pump side medicine setting information, 76... Medicine setting information re-input determination section (program), 77.
  • Re-entry drug Setting information storage unit 77a ⁇ ⁇ ⁇ pump side reenter agents such setting information

Landscapes

  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medical Informatics (AREA)
  • Primary Health Care (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Abstract

[Problem] To provide a medical-information management system and the like which make it possible to easily determine the suitability or the like of a drug combination, and to reduce the burden on a health care provider or the like. [Solution] A medical-information management system (1) for determining the suitability of combination dose information (75a) in the information for a plurality of drugs to be administered to a patient using a plurality of medical devices (70a), and when determined that the combination dose information for the multiple pieces of drug information is unsuitable, providing drug-combination-unsuitable information, and requesting the user to re-input combination dose information for the multiple pieces of drug information.

Description

医療情報管理システム及び医療情報管理方法Medical information management system and medical information management method

 本発明は、例えば、病院等で使用する薬剤情報等の医療情報を管理する医療情報管理システム及び医療情報管理方法に関するものである。 The present invention relates to a medical information management system and a medical information management method for managing medical information such as drug information used in hospitals, for example.

 従来より、病院等では、薬剤を患者に適切に投与するために、輸液ポンプ等が用いられている(例えば、特許文献1)。 Conventionally, in hospitals and the like, infusion pumps and the like have been used in order to appropriately administer drugs to patients (for example, Patent Document 1).

 また、病院では、患者に対して、連続して複数の薬剤を投与する場合や、複数の薬剤を同時に投与する場合がある。このような場合は、上述の輸液ポンプを複数台用意して、ラック装置に配置すると共に、ラック装置を経由して、これらの輸液ポンプを連携させ、薬剤を患者に投与していた。 Also, in hospitals, there are cases where a plurality of drugs are administered continuously to a patient or a plurality of drugs are administered simultaneously. In such a case, a plurality of the above-mentioned infusion pumps were prepared and arranged in the rack device, and these infusion pumps were linked via the rack device to administer the drug to the patient.

特開2011-87678号公報JP 2011-87678 A

 しかし、薬剤によっては、組み合わせて投与してはならない等の場合があり、薬剤の組み合わせ投与には細心の注意が求められ、医療従事者等の負担が増すという問題があった。 However, depending on the drug, there is a case where it must not be administered in combination, and there has been a problem in that careful attention is required for the combined administration of the drug, which increases the burden on medical staff.

 そこで、本発明は、薬剤の組合せの適否等を容易に判断することができ、医療従事者等の負担を減らすことができる医療情報管理システム及び医療情報管理方法を提供することを目的とする。 Therefore, an object of the present invention is to provide a medical information management system and a medical information management method that can easily determine the suitability of a combination of medicines and reduce the burden on medical staff.

 前記目的は、本発明にあっては、複数の医療機器を用いて、対象者に投与される複数の薬剤情報の組合せ投与情報の適否を判断し、当該複数の薬剤情報の組合せ投与情報が不適であるときは、当該薬剤組合せ不適情報を提供し、利用者に前記複数の薬剤情報の組合せ投与情報の再入力を求める構成となっていることを特徴とする医療情報管理システムにより達成される。 In the present invention, the object is to determine the suitability of combination administration information of a plurality of pieces of drug information administered to a subject using a plurality of medical devices, and the combination administration information of the plurality of pieces of drug information is inappropriate. Is achieved by a medical information management system characterized in that the drug combination inappropriate information is provided and the user is requested to re-input combination administration information of the plurality of drug information.

 前記構成によれば、複数の医療機器を用いて、対象者に投与される複数の薬剤情報の組合せ投与情報の適否を判断し、当該複数の薬剤情報の組合せ投与情報が不適であるときは、当該薬剤組合せ不適情報を提供する構成となっている。
 このため、組み合わせて投与してはならない複数の薬剤の組合せ投与を医療従事者等の利用者が入力したときは、利用者に対して、薬剤組合せ不適情報が提供されるので、利用者は、当該薬剤の組合せの選択が不適であることを知ることができる。
 また、利用者は自己が入力した薬剤の組合せが不適であることを知ることができるので、利用者が誤って不適切な薬剤の組合せ投与を患者等に対して行うことを未然に防ぐことができる。すなわち、利用者は、薬剤の組合せの適否等を容易に判断することができ、医療従事者等の負担を減らすことができる。
According to the above configuration, using a plurality of medical devices, it is determined whether or not combination administration information of a plurality of drug information to be administered to a subject, and when the combination administration information of the plurality of drug information is inappropriate, It is the structure which provides the said drug combination inadequate information.
For this reason, when a user such as a medical worker inputs combination administration of a plurality of drugs that should not be administered in combination, drug combination inadequate information is provided to the user. It can be seen that the selection of the drug combination is inappropriate.
In addition, since the user can know that the combination of drugs entered by himself / herself is inappropriate, it is possible to prevent the user from inadvertently administering an inappropriate combination of drugs to the patient. it can. That is, the user can easily determine the suitability of the combination of medicines, and can reduce the burden on medical staff.

 また、前記構成では、利用者に前記複数の薬剤情報の組合せ投与情報の再入力を求める構成となっているので、利用者は、円滑に適切な薬剤情報の組合せ投与情報を入力することができる。 Moreover, in the said structure, since it becomes the structure which asks a user to re-input the combination administration information of these several chemical | medical agent information, the user can input the combination administration information of suitable chemical | medical agent information smoothly. .

 好ましくは、前記薬剤組合せ不適情報は、絶対的組合せ不可薬剤情報と相対的組合せ不可薬剤情報を含み、前記薬剤組合せ不適情報として、前記相対的組合せ不可薬剤情報を利用者に提供した後、利用者が、同一の前記複数の薬剤情報の組合せ投与情報を再入力したときは、再び前記薬剤組合せ不適情報を提供しない構成となっていることを特徴とする。 Preferably, the drug combination inadequate information includes information on drugs that cannot be combined absolutely and information on drugs that cannot be combined in combination, and the user is provided with the information on drugs that cannot be combined as relative information that is not suitable for combination. However, when the combination administration information of the same plurality of pieces of drug information is re-input, the drug combination inappropriate information is not provided again.

 前記構成によれば、薬剤組合せ不適情報は、絶対的組合せ不可薬剤情報と相対的組合せ不可薬剤情報を含み、薬剤組合せ不適情報として、相対的組合せ不可薬剤情報を利用者に提供した後、利用者が、同一の前記複数の薬剤情報の組合せ投与情報を再入力したときは、再び薬剤組合せ不適情報を提供しない構成となっている。
 すなわち、薬剤組合せ不適情報は、絶対的に薬剤の組合せを回避すべき「絶対的組合せ不可薬剤情報」と、一般的に、薬剤の組合せを可能であれば、回避すべきである「相対的組合せ不可薬剤情報」を含んでいる。
 そして、「相対的組合せ不可薬剤情報」は、場合によっては、組合せ投与が認められる情報である。したがって、利用者が入力した複数の薬剤情報の組合せ投与情報が「相対的組合せ不可薬剤情報」であるときは、その事実を利用者に報知し、利用者がその事実を認識したうえで、同じ複数の薬剤情報の組合せ投与情報を入力したときは、その入力を認める構成となっている。
 したがって、利用者にとって使い易いシステムとなっている。
According to the above configuration, the drug combination inadequate information includes information on drugs that cannot be combined absolutely and information on drugs that cannot be combined in combination. However, when the combination administration information of the same plurality of drug information is re-input, the drug combination inappropriate information is not provided again.
That is, the drug combination inadequate information includes “absolute combination impossible drug information” that should absolutely avoid the combination of drugs, and “relative combination” that should generally be avoided if possible. "Unavailable drug information".
The “relative combination impossible drug information” is information that allows combination administration in some cases. Therefore, when the combination administration information of a plurality of pieces of drug information input by the user is “relative combination impossible drug information”, the fact is notified to the user, and the user recognizes the fact and the same. When the combination administration information of a plurality of drug information is input, the input is permitted.
Therefore, the system is easy to use for the user.

 好ましくは、前記複数の医療機器は、ラック部に配置され、このラック部は医療情報管理装置と通信可能な構成とされ、前記医療情報管理装置は、前記複数の薬剤情報の組合せ投与情報を前記ラック部から取得して、この取得した複数の薬剤情報の組合せ投与情報に基づき、その適否を判断し、不適であるときは、前記薬剤組合せ不適情報を生成する構成となっていることを特徴とする。 Preferably, the plurality of medical devices are arranged in a rack unit, and the rack unit is configured to be able to communicate with a medical information management device, and the medical information management device receives combination administration information of the plurality of drug information. It is obtained from the rack unit, based on the combination administration information of the obtained plurality of drug information, the suitability is determined, and when it is inappropriate, the drug combination inappropriate information is generated. To do.

 前記構成によれば、前記複数の医療機器は、ラック部に配置され、このラック部は医療情報管理装置と通信可能な構成とされ、医療情報管理装置は、複数の薬剤情報の組合せ投与情報を前記ラック部から取得して、この取得した複数の薬剤情報の組合せ投与情報に基づき、その適否を判断し、不適であるときは、薬剤組合せ不適情報を生成する構成となっている。
 このため、複数の薬剤の組合せ投与を複数の医療機器及びラック部を用いて行う場合でも、その適否を医療情報管理装置で行い、その結果を円滑に医療機器及びラック部に伝えることで、円滑に薬剤組合せ不適情報を利用者に報知等することができる。
According to the configuration, the plurality of medical devices are arranged in a rack unit, and the rack unit is configured to be able to communicate with a medical information management device. The medical information management device stores combination administration information of a plurality of drug information. Based on the combination administration information of the plurality of pieces of drug information acquired from the rack unit, the suitability is determined, and if it is inappropriate, the drug combination inappropriate information is generated.
For this reason, even when a plurality of medicines are administered in combination using a plurality of medical devices and rack units, the medical information management device performs the suitability and smoothly transmits the results to the medical devices and rack units. In addition, it is possible to notify the user of inappropriate drug combination information.

 前記目的は、本発明にあっては、複数の医療機器を用いて、対象者に投与される複数の薬剤情報の組合せ投与情報の適否を判断し、当該複数の薬剤情報の組合せ投与情報が不適であるときは、当該薬剤組合せ不適情報を提供し、利用者に前記複数の薬剤情報の組合せ投与情報の再入力を求める構成となっていることを特徴とする医療情報管理方法により達成される。 In the present invention, the object is to determine the suitability of combination administration information of a plurality of pieces of drug information administered to a subject using a plurality of medical devices, and the combination administration information of the plurality of pieces of drug information is inappropriate. Is achieved by a medical information management method characterized in that the drug combination inappropriate information is provided and the user is requested to re-input combination administration information of the plurality of drug information.

 以上説明したように、本発明によれば、薬剤の組合せの適否等を容易に判断することができ、医療従事者等の負担を減らすことができる医療情報管理システム及び医療情報管理方法を提供することができる。 As described above, according to the present invention, a medical information management system and a medical information management method that can easily determine the suitability of a combination of medicines and reduce the burden on medical staff and the like are provided. be able to.

本発明の「医療情報管理システム」の実施の形態に係る「薬剤組合せ管理システム」を示す概略図である。It is the schematic which shows the "medicine combination management system" which concerns on embodiment of the "medical information management system" of this invention. 図1に示す輸液ポンプを示す概略ブロック図である。It is a schematic block diagram which shows the infusion pump shown in FIG. 図1に示すラック装置を示す概略ブロック図である。It is a schematic block diagram which shows the rack apparatus shown in FIG. 図1に示す管理サーバを示す概略ブロック図である。It is a schematic block diagram which shows the management server shown in FIG. 図4の「第1各種情報記憶部」の内容を示す概略ブロック図である。FIG. 5 is a schematic block diagram illustrating contents of a “first various information storage unit” in FIG. 4. 図4の「第2各種情報記憶部」の内容を示す概略ブロック図である。It is a schematic block diagram which shows the content of the "2nd various information storage part" of FIG. 図1に示す「薬剤組合せ管理システム」の主な動作例等を示す概略フローチャートである。3 is a schematic flowchart showing a main operation example of the “drug combination management system” shown in FIG. 1. 図1に示す「薬剤組合せ管理システム」の主な動作例等を示す他の概略フローチャートである。6 is another schematic flowchart showing a main operation example of the “drug combination management system” shown in FIG. 1. 図1に示す「薬剤組合せ管理システム」の主な動作例等を示す他の概略フローチャートである。6 is another schematic flowchart showing a main operation example of the “drug combination management system” shown in FIG. 1. 図1に示す「薬剤組合せ管理システム」の主な動作例等を示す他の概略フローチャートである。6 is another schematic flowchart showing a main operation example of the “drug combination management system” shown in FIG. 1.

 以下、この発明の好適な実施の形態を添付図面等を参照しながら、詳細に説明する。
 尚、以下に述べる実施の形態は、本発明の好適な具体例であるから、技術的に好ましい種々の限定が付されているが、本発明の範囲は、以下の説明において特に本発明を限定する旨の記載がない限り、これらの態様に限られるものではない。
Preferred embodiments of the present invention will be described below in detail with reference to the accompanying drawings.
The embodiments described below are preferred specific examples of the present invention, and thus various technically preferable limitations are given. However, the scope of the present invention is particularly limited in the following description. Unless otherwise stated, the present invention is not limited to these embodiments.

 図1は、本発明の「医療情報管理システム」の実施の形態に係る「薬剤組合せ管理システム1」を示す概略図である。
 図1に示すように、薬剤組合せ管理システム1は、医療機器である例えば、2台の輸液ポンプ70a、70bを有している。
 これら輸液ポンプ70a等は、例えば、それぞれ異なる薬剤A、薬剤Bを対象者である例えば、患者に投与するためのものである。すなわち、輸液ポンプ70a等は、その内部に薬剤A等の薬液を送液する図示しないチューブ等を配置することができる構成となっており、そのチューブを押圧等して、しごく等の動作をすることで、チューブ内の送液される薬液の流量等を制御する構成となっている。
FIG. 1 is a schematic diagram showing a “drug combination management system 1” according to an embodiment of a “medical information management system” of the present invention.
As shown in FIG. 1, the medicine combination management system 1 includes, for example, two infusion pumps 70a and 70b which are medical devices.
These infusion pumps 70a and the like are, for example, for administering different drugs A and B to a subject, for example, a patient. That is, the infusion pump 70a and the like have a configuration in which a tube (not shown) that feeds a drug solution such as the drug A can be disposed therein, and performs operations such as pressing by pressing the tube. Thus, the flow rate of the chemical solution fed in the tube is controlled.

 また、これら3台の輸液ポンプ70a等は、図1に示すラック部である例えば、ラック装置10を有している。
 ラック装置10は、ラック本体11を有すると共に、その下部に、他の機器と通信するための通信ボックス15を備えている。
 また、ラック本体11は、2台の輸液ポンプ70a、70b、を図1の矢印で示すように、装着するための2つの装着部を含む3つの装着部(第1装着部12、第2装着部13、第3装着部14)を有している。
 すなわち、図1の2つの輸液ポンプ70a、70bはそれぞれ、第1装着部12、第2装着部13に配置される構成となっている。
 なお、本実施の形態では、説明の便宜上、2台の輸液ポンプ70a、70bのみが第1装着部12、第2装着部13に配置される場合について説明するが、図2に示すラック装置10は3台の輸液ポンプが配置可能な構成となっている。
Further, these three infusion pumps 70a and the like have, for example, a rack device 10 which is a rack portion shown in FIG.
The rack apparatus 10 has a rack body 11 and a communication box 15 for communicating with other devices at the lower part thereof.
Further, the rack body 11 includes three mounting parts (first mounting part 12 and second mounting part) including two mounting parts for mounting two infusion pumps 70a and 70b as indicated by arrows in FIG. Part 13 and third attachment part 14).
That is, the two infusion pumps 70a and 70b in FIG. 1 are arranged in the first mounting portion 12 and the second mounting portion 13, respectively.
In the present embodiment, for convenience of explanation, a case where only two infusion pumps 70a and 70b are arranged in the first mounting portion 12 and the second mounting portion 13 will be described. However, the rack apparatus 10 shown in FIG. Has a configuration in which three infusion pumps can be arranged.

 また、薬剤組合せ管理システム1は、図1に示すように、医療情報管理装置である例えば、管理サーバ30を有し、この管理サーバ30はラック装置10と通信可能な構成となっている。 Further, as shown in FIG. 1, the medicine combination management system 1 includes, for example, a management server 30 that is a medical information management device, and the management server 30 is configured to be able to communicate with the rack device 10.

 ところで、薬剤組合せ管理システム1は、例えば、同一の患者に、図1の2つの輸液ポンプ70a、70bが送液する薬液(薬剤)を同時に、又は連続して投与する場合は、各輸液ポンプ70a等は、ラック装置10を介して連携して送液する構成となっている。 By the way, when the medicine combination management system 1 administers the medicine (medicine) sent by the two infusion pumps 70a and 70b in FIG. 1 to the same patient simultaneously or successively, for example, each infusion pump 70a. Etc. are configured to send liquids in cooperation via the rack device 10.

 また、図1に示すように、輸液ポンプ70a等は、各種情報を表示する表示部である例えば、輸液ポンプ側ディスプレイ71を有すると共に、各種情報を入力する入力部である輸液ポンプ側入力装置72も有している。
 この輸液ポンプ側入力装置72は、具体的には、ダイヤルや入力ボタン等となっている。
As shown in FIG. 1, the infusion pump 70a and the like have an infusion pump side display 71 that is a display unit that displays various information, for example, and an infusion pump side input device 72 that is an input unit that inputs various information. Also have.
Specifically, the infusion pump side input device 72 is a dial, an input button, or the like.

 ところで、図1に示す輸液ポンプ70a等、ラック装置10及び管理サーバ30は、コンピュータを有し、コンピュータは、図示しないCPU(Central Processing Unit)、RAM(Random Access Memory)、ROM(Read Only Memory)等を有し、これらは、バスを介して接続されている。 By the way, the rack apparatus 10 and the management server 30 such as the infusion pump 70a shown in FIG. 1 have a computer, and the computer includes a CPU (Central Processing Unit), a RAM (Random Access Memory), and a ROM (Read Only Memory). Etc., and these are connected via a bus.

 図2は、図1に示す輸液ポンプ70a等を示す概略ブロック図である。
 図2に示すように、輸液ポンプ70a等は、「輸液ポンプ制御部73」を有している。この輸液ポンプ制御部73は、図1に示す「輸液ポンプ側入力装置72」や「輸液ポンプ側ディスプレイ71」を制御すると共に、図1の「管理サーバ30」等との通信を行う「輸液ポンプ側通信装置74」を制御する。また、「輸液ポンプ制御部73」は、図2に示す各記憶部や判断部(プログラム)等も制御するが、これらの構成については後述する。
FIG. 2 is a schematic block diagram showing the infusion pump 70a and the like shown in FIG.
As shown in FIG. 2, the infusion pump 70 a and the like have an “infusion pump control unit 73”. The infusion pump control unit 73 controls the “infusion pump side input device 72” and the “infusion pump side display 71” shown in FIG. 1, and communicates with the “management server 30” in FIG. Side communication device 74 ". The “infusion pump control unit 73” also controls each storage unit, determination unit (program), and the like shown in FIG. 2, and these configurations will be described later.

 図3は、図1に示すラック装置10を示す概略ブロック図である。
 図3に示すように、ラック装置10は、「ラック制御部16」を有している。この「ラック制御部16」は、図1に示す「第1装着部12」、「第2装着部13」、「第3装着部14」及び「通信ボックス15」を制御すると共に、各種情報を表示する「ラック側ディスプレイ17」や図1の「管理サーバ30」等との通信を行う「ラック側通信装置18」を制御する。また、「ラック制御部16」は、図3に示す各記憶部や処理部(プログラム)等も制御するが、これらの構成については後述する。
FIG. 3 is a schematic block diagram showing the rack apparatus 10 shown in FIG.
As illustrated in FIG. 3, the rack apparatus 10 includes a “rack control unit 16”. The “rack control unit 16” controls the “first mounting unit 12”, the “second mounting unit 13”, the “third mounting unit 14”, and the “communication box 15” shown in FIG. The “rack-side communication device 18” that performs communication with the “rack-side display 17” to be displayed and the “management server 30” in FIG. 1 is controlled. The “rack control unit 16” also controls each storage unit, processing unit (program), and the like shown in FIG. 3, and these configurations will be described later.

 図4は、図1に示す管理サーバ30を示す概略ブロック図である。
 図4に示すように、管理サーバ30は、「サーバ制御部31」を有している。この「サーバ制御部31」は、各種情報を入力する「サーバ側入力装置32」、各種情報を表示する「サーバ側ディスプレイ33」及び図1のラック装置10等と通信する「サーバ側通信装置34」を制御すると共に、図4に示す「第1各種記憶部40」及び「第2各種記憶部50」も制御する。
 図5及び図6は、それぞれ、図4の「第1各種情報記憶部40」及び「第2各種情報記憶部50」の内容を示す概略ブロック図である。これらの内容については後述する。
FIG. 4 is a schematic block diagram showing the management server 30 shown in FIG.
As illustrated in FIG. 4, the management server 30 includes a “server control unit 31”. The “server control unit 31” includes a “server-side input device 32” for inputting various information, a “server-side display 33” for displaying various information, and a “server-side communication device 34” for communicating with the rack device 10 of FIG. ”And“ first various storage units 40 ”and“ second various storage units 50 ”shown in FIG. 4 are also controlled.
5 and 6 are schematic block diagrams showing the contents of “first various information storage unit 40” and “second various information storage unit 50” in FIG. 4, respectively. These contents will be described later.

 図7乃至図10は、図1に示す「薬剤組合せ管理システム1」の主な動作例等を示す概略フローチャートである。以下、図7乃至図10のフローチャートに従い、その動作等を説明すると共に、図1乃至図6の構成等についても説明する。 7 to 10 are schematic flowcharts showing main operation examples of the “drug combination management system 1” shown in FIG. Hereinafter, the operation and the like will be described according to the flowcharts of FIGS. 7 to 10, and the configurations and the like of FIGS. 1 to 6 will be described.

 本実施の形態では、利用者である例えば、看護師等の医療従事者が、図1のラック装置10に輸液ポンプ70a、70bを装着し、輸液ポンプ70a、70b、が、それぞれ送液を制御する薬剤A、薬剤Bのデータを入力し、これらを患者に同時に、又は連続して投与しようとする場合を例に以下、説明する。 In the present embodiment, for example, a medical worker such as a nurse, who is a user, attaches the infusion pumps 70a and 70b to the rack apparatus 10 in FIG. 1, and the infusion pumps 70a and 70b control the liquid feeding, respectively. The following describes an example in which data of the medicine A and the medicine B to be inputted are input to the patient simultaneously or successively.

 先ず、図7のステップST(以下「ST」という)1では、看護師等が、上記薬剤A、薬剤Bを、それぞれ、輸液ポンプ70a、70bで制御すること、及びこれらを同一又は連続して連携して投与するための情報を輸液ポンプ70aに入力する。
 具体的には、輸液ポンプ70a等へ薬剤等の設定情報である「薬剤等設定情報(薬剤名(薬剤名A等)、連携動作対象の他の輸液ポンプ番号(例えば、70b等)」を入力する。
First, in step ST (hereinafter referred to as “ST”) 1 in FIG. 7, a nurse or the like controls the medicine A and medicine B with the infusion pumps 70 a and 70 b, respectively, and these are the same or continuous. Information for administration in cooperation is input to the infusion pump 70a.
Specifically, “medicine setting information (drug name (drug name A, etc.), other infusion pump number (for example, 70b), etc.) to be linked” is input to the infusion pump 70a etc. To do.

 次いで、ST2へ進む。ST2では、輸液ポンプ70a、70bは、それぞれに入力された「薬剤等設定情報」を、当該輸液ポンプ70a、70bの輸液ポンプ番号(70a、70b)と関連付けて、図2の「ポンプ側薬剤等設定情報75a」として、「ポンプ側薬剤等設定情報記憶部75」に記憶させる。
 本実施の形態では、図2の「ポンプ側薬剤等設定情報75a」に示すように「輸液ポンプ番号70aは、薬剤Aを送液し、輸液ポンプ70bと連携(組合せ)するように登録される。
 一方、図示はされていないが、図の輸液ポンプ70bでも、薬剤Bを送液し、輸液ポンプ70aと連携するように登録される。
 なお、本実施の形態では、連携として、例えば、同時投与を例としている。したがって、本実施の形態では、輸液ポンプ70aの薬剤Aと、輸液ポンプ70bの薬剤Bとは、患者に対して同時に投与されることになる。
Next, the process proceeds to ST2. In ST2, the infusion pumps 70a and 70b associate the “medicine etc. setting information” input thereto with the infusion pump numbers (70a and 70b) of the infusion pumps 70a and 70b. As “setting information 75a”, it is stored in the “pump side medicine setting information storage section 75”.
In the present embodiment, as shown in “Pump side medicine setting information 75a” in FIG. 2, “infusion pump number 70a is registered so as to deliver medicine A and cooperate (combine) with infusion pump 70b. .
On the other hand, although not shown in the figure, the infusion pump 70b in the figure also sends the medicine B and is registered so as to cooperate with the infusion pump 70a.
In the present embodiment, as the cooperation, for example, simultaneous administration is taken as an example. Therefore, in the present embodiment, the medicine A of the infusion pump 70a and the medicine B of the infusion pump 70b are administered simultaneously to the patient.

 また、「ポンプ側薬剤等設定情報75a」が、「複数の薬剤情報の組合せ投与情報」の一例となっている。 Also, “pump side medicine setting information 75a” is an example of “combination administration information of a plurality of medicine information”.

 次いで、ST3へ進む。ST3では、輸液ポンプ70aは、図2の「ポンプ側薬剤等設定情報記憶部75」の「ポンプ側薬剤等設定情報75a」等をラック装置10へ送信する。また、輸液ポンプ70bも同様にラック装置10へ送信する。 Next, proceed to ST3. In ST3, the infusion pump 70a transmits the “pump side medicine setting information 75a” in the “pump side medicine setting information storage unit 75” of FIG. The infusion pump 70b also transmits to the rack device 10 in the same manner.

 次いで、ST4へ進む。ST4では、ラック装置10は、各輸液ポンプ70a、70bから受信した「ポンプ側薬剤等設定情報75a」等を当該ラック番号、例えば、R001」と関連付けて「ラック側薬剤等設定情報19a」として「ラック側薬剤等設定情報記憶部19」に記憶する(図3参照)。
 すなわち、図3の「ラック側薬剤等設定情報19a」に示すように、当該ラック装置(R001)に関する輸液ポンプ70a、70bの送液薬剤A、Bとそれらの連携等について関連付けて記憶される。
Next, the process proceeds to ST4. In ST4, the rack device 10 associates the “pump side medicine setting information 75a” received from each of the infusion pumps 70a and 70b with the rack number, for example, R001, as “rack side medicine etc. setting information 19a”. The information is stored in the rack side medicine etc. setting information storage unit 19 ”(see FIG. 3).
That is, as shown in “rack side medicine setting information 19a” in FIG. 3, the liquid feeding medicines A and B of the infusion pumps 70a and 70b related to the rack apparatus (R001) and their cooperation are stored in association with each other.

 次いで、ST5へ進む。ST5では、図3の「ポンプ連携動作情報有無判断処理部(プログラム)20」が動作し、「ラック側薬剤等設定情報19a」に「連携動作」情報が存在するか否かを判断する。 Next, proceed to ST5. In ST5, the “pump cooperation operation information presence / absence determination processing unit (program) 20” of FIG. 3 operates to determine whether or not “cooperation operation” information exists in the “rack side medicine setting information 19a”.

 ST5で「ラック側薬剤等設定情報19a」に「連携動作」情報が存在しないと判断されたときは、複数の薬剤の同時又は連続投与がなく、組合せ投与による危険性がないと判断され、ST6へ進む。
 ST6では、ラック装置10が輸液ポンプ70a、70bに対して、それらの動作開始情報(輸液開始)を送信し、輸液ポンプ70a、70bが動作開始し、患者に対する送液が開始される。
When it is determined in ST5 that the “rack side medicine setting information 19a” does not include “cooperation operation” information, it is determined that there is no simultaneous or continuous administration of a plurality of medicines and there is no risk due to combination administration, and ST6 Proceed to
In ST6, the rack apparatus 10 transmits the operation start information (infusion start) to the infusion pumps 70a and 70b, the infusion pumps 70a and 70b start to operate, and the infusion to the patient is started.

 一方、ST5で、「ラック側薬剤等設定情報19a」に「連携動作」情報が存在する場合、例えば、図3の「ラック側薬剤等設定情報19a」に記載のときは、ST7へ進む。ST7では、ラック装置10が管理サーバ30に「ラック側薬剤等設定情報10a」を送信する。 On the other hand, if “cooperation operation” information exists in “rack side medicine setting information 19a” in ST5, for example, if it is described in “rack side medicine etc. setting information 19a” in FIG. In ST 7, the rack device 10 transmits “rack side medicine setting information 10 a” to the management server 30.

 次いで、ST8へ進む。ST8では、管理サーバ30が、受信した「ラック側薬剤等設定情報19a」を「サーバ側薬剤等設定情報」として、図5の「サーバ側薬剤等設定情報記憶部41」に記憶する。 Next, proceed to ST8. In ST8, the management server 30 stores the received “rack side medicine setting information 19a” as “server side medicine etc. setting information” in the “server side medicine etc. setting information storage unit 41” of FIG.

 次いで、ST9へ進む。ST9では、図5の「組合せ不可情報判断処理部(プログラム)42」が動作し、図5「サーバ側薬剤等設定情報記憶部41」の「サーバ側薬剤等設定情報」と、「組合せ不可薬剤情報記憶部43」の「組合せ不可薬剤情報43a」とを参照し、「絶対的組合せ不可薬剤情報」又は「相対的組合せ不可薬剤情報」に該当する「連携動作」情報が「サーバ側薬剤等設定情報」に存在するか否かを判断する。 Next, proceed to ST9. In ST9, the “combination impossible information determination processing unit (program) 42” in FIG. 5 operates, and “server side medicine etc. setting information storage unit 41” in FIG. The “cooperative operation” information corresponding to “absolute combination impossible drug information” or “relative combination impossible drug information” is referred to as “server side drug etc. setting” with reference to “uncombinable drug information 43a” in the information storage unit 43. It is determined whether or not the information exists.

 このように、「組合せ不可薬剤情報43a」には、薬剤の組合せである同時や連続投与等が絶対的に回避すべきであり、禁止される「絶対的組合せ不可薬剤情報」と、薬剤の組合せが一般的に可能であれば回避すべきである「相対的組合せ不可薬剤情報」とがある。そして、本実施の形態では,「絶対的組合せ不可薬剤情報」として、例えば、薬剤Aと薬剤Cであり、「相対的組合せ不可薬剤情報」として、例えば、薬剤Aと薬剤Bである。 Thus, in the “uncombinable drug information 43a”, simultaneous or continuous administration that is a combination of drugs should be absolutely avoided, and the prohibited “absolute combination impossible drug information” and the combination of drugs are prohibited. There is "relative combination impossible drug information" that should generally be avoided if possible. In the present embodiment, “absolute combination impossible drug information” is, for example, drug A and drug C, and “relative combination impossible drug information” is, for example, drug A and drug B.

 これら「絶対的組合せ不可薬剤情報」や「相対的組合せ不可薬剤情報」が「薬剤組合せ不適情報」の一例となっている。 These “absolute combination impossible drug information” and “relative combination impossible drug information” are examples of “drug combination inadequate information”.

 次いで、ST10へ進む。ST10では、図5の「組合せ不可情報判断処理部(プログラム)42」が動作し、図5の「組合せ不可薬剤情報43a」の「絶対的組合せ不可薬剤情報」又は「相対的組合せ不可薬剤情報」に該当する「連携動作」情報が「サーバ側薬剤等設定情報」に存在するか否かを判断し、存在しないと判断したときは、ST11へ進む。 Next, proceed to ST10. In ST10, the “combination impossible information determination processing unit (program) 42” of FIG. 5 operates, and “absolute combination impossible drug information” or “relative combination impossible drug information” of “uncombinable drug information 43a” of FIG. It is determined whether or not the “cooperation operation” information corresponding to is present in the “server-side medicine etc. setting information”.

 ST10で、「サーバ側薬剤等設定情報」に「絶対的組合せ不可薬剤情報」又は「相対的組合せ不可薬剤情報」に該当する「連携動作」情報が存在しないと判断されたときは、複数の薬剤の同時又は連続投与があっても、組合せ投与による危険性がないと判断され、ST11へ進む。
 ST11では、管理サーバ30がラック装置10を介して、輸液ポンプ70a、70bに対して、それらの動作開始情報(輸液開始)を送信し、輸液ポンプ70a、70bが動作開始し、患者に対する送液が開始される。
In ST10, when it is determined that “cooperation information” corresponding to “absolute combination impossible drug information” or “relative combination impossible drug information” does not exist in “server side drug etc. setting information”, a plurality of drugs Even if there is simultaneous or continuous administration, it is determined that there is no risk of combination administration, and the process proceeds to ST11.
In ST11, the management server 30 transmits the operation start information (infusion start) to the infusion pumps 70a and 70b via the rack device 10, and the infusion pumps 70a and 70b start to operate, and the infusion fluid is supplied to the patient. Is started.

 一方、ST10で、「サーバ側薬剤等設定情報」に「絶対的組合せ不可薬剤情報」又は「相対的組合せ不可薬剤情報」に該当する「連携動作」情報が存在すると判断されたときは、ST12へ進む。
 ST12では、図5の「組合せ不可情報判断処理部(プログラム)42」が動作し、「絶対的組合せ不可薬剤情報」又は「相対的組合せ不可薬剤情報」に該当する連携動作情報を「組合せ不可薬剤該当情報」として「組合せ不可薬剤該当情報記憶部44」に記憶する。
 本実施の形態では、「組合せ不可薬剤該当情報」として、例えば、ラック番号(R001)の輸液ポンプ番号(70a)、薬剤(A)と輸液ポンプ番号(70b)、薬剤(B)との「連携動作」は「相対的組合せ不可薬剤情報」に該当するとして、「組合せ不可薬剤該当情報記憶部44」に記憶する。
On the other hand, if it is determined in ST10 that the “server side drug etc. setting information” includes “cooperation information” corresponding to “absolute combination impossible drug information” or “relative combination impossible drug information”, the process proceeds to ST12. move on.
In ST12, the “combination impossible information determination processing unit (program) 42” in FIG. 5 operates, and the cooperative operation information corresponding to “absolute combination impossible drug information” or “relative combination impossible drug information” is displayed as “uncombinable drug information”. The information is stored in the “unmatchable medicine corresponding information storage unit 44” as “corresponding information”.
In the present embodiment, for example, the “incompatibility drug applicable information” includes “infusion pump number (70a) of rack number (R001), drug (A), infusion pump number (70b), and“ cooperation ”of drug (B). The “operation” corresponds to “relative combination impossible drug information” and is stored in the “uncombinable drug corresponding information storage unit 44”.

 次いで、ST13へ進む。ST13では、管理サーバ30は、「組合せ不可薬剤該当情報記憶部44」の「組合せ不可薬剤該当情報」を当該ラック装置10、本実施の形態では、例えば、ラック番号(R001))に送信する。 Next, proceed to ST13. In ST13, the management server 30 transmits the “uncombinable drug applicable information” in the “uncombinable drug applicable information storage unit 44” to the rack device 10, in this embodiment, for example, the rack number (R001).

 次いで、ST14へ進む。ST14では、ラック装置10は、受信した「組合せ不可薬剤該当情報」を、該当する輸液ポンプ70a、輸液ポンプ70bへ送信する。 Next, proceed to ST14. In ST14, the rack apparatus 10 transmits the received “uncombinable drug corresponding information” to the corresponding infusion pump 70a and infusion pump 70b.

 次いで、ST15へ進む。ST15では、図1の輸液ポンプ70a、70bは、輸液ポンプ側ディスプレイ71等に、例えば、輸液ポンプ番号(70a)の薬剤Aと輸液ポンプ番号(70b)の薬剤Bとの「連携動作」、すなわち、組合せ投与は、「相対的組合せ不可薬剤情報」である旨、表示され、再入力画面が表示される。
 したがって、輸液ポンプ70a等に薬剤A等の情報の入力を行った看護師等は,当該入力による薬剤Aと薬剤Bとの連携(組合せ)が、一般的に可能であれば回避すべきである「相対的組合せ不可薬剤情報」であることを認識することができ、入力を変更する機会が与えられる。
Next, the process proceeds to ST15. In ST15, the infusion pumps 70a and 70b in FIG. 1 display on the infusion pump-side display 71 or the like, for example, “cooperation operation” between the medicine A of the infusion pump number (70a) and the medicine B of the infusion pump number (70b). The combination administration is displayed as “relative combination impossible drug information”, and a re-input screen is displayed.
Therefore, a nurse or the like who has input information such as drug A to the infusion pump 70a or the like should generally avoid cooperation (combination) between drug A and drug B by the input if possible. It is possible to recognize that it is “relative combination impossible drug information”, and an opportunity to change the input is given.

 したがって、誤って係る薬剤Aと薬剤Bとの組合せを入力した場合は、再入力をすることで正しい組合せに変更でき、患者に対して不適切な薬剤の組合せ投与を行うことを未然に防ぐことができる。
 すなわち、看護師等は、薬剤の組合せの適否等を容易に判断することができ、看護師等の負担を減らすことができる。
 また、看護師等は、薬剤の投与情報の再入力が求められるので、円滑に適切な薬剤の組合せ投与情報を入力することができる。
Therefore, when the combination of the medicine A and the medicine B is input by mistake, it can be changed to the correct combination by re-input, and it is possible to prevent an inappropriate combination of medicines from being administered to the patient. Can do.
That is, a nurse or the like can easily determine the suitability of a combination of drugs, and can reduce the burden on the nurse or the like.
In addition, since nurses and the like are required to re-enter drug administration information, it is possible to smoothly input appropriate drug combination administration information.

 次いで、図9のST16へ進む。ST16では、輸液ポンプ70a、70bの輸液ポンプ側ディスプレイ71等の再入力画面で、看護師等が、薬剤等設定情報を再入力したか否かが判断される。
 すなわち、図2の「薬剤等設定情報再入力判断部(プログラム)76」が動作し、輸液ポンプ側ディスプレイ73等に表示された「再入力画面」で「薬剤等設定情報(薬剤名、連携動作対象の他の輸液ポンプ番号)」が再入力されたか否かを判断する。
 本実施の形態では、一度入力された薬剤Aと薬剤Bとの組合せは「相対的組合せ不可薬剤情報」であると判断されているが、これは、看護師等が担当医師の処方通りに入力したものであるため、看護師等は、再入力でも、同様に入力する。
Next, the process proceeds to ST16 in FIG. In ST16, it is determined on the re-input screen of the infusion pump-side display 71 etc. of the infusion pumps 70a and 70b whether or not the nurse or the like has re-entered the drug etc. setting information.
That is, the “drug etc. setting information re-input determination unit (program) 76” of FIG. 2 is operated, and the “re-input screen” displayed on the infusion pump-side display 73 etc. It is determined whether or not “the other infusion pump number of the subject” has been re-input.
In the present embodiment, it is determined that the combination of the medicine A and the medicine B once inputted is “relative combination impossible medicine information”, which is inputted by the nurse or the like as prescribed by the doctor in charge. Therefore, the nurse or the like inputs the same in the case of re-input.

 ST16で、再入力されたと判断されたときは、ST17へ進む。ST17では、図2の「薬剤等設定情報再入力判断部(プログラム)76」が動作し、当該再入力の薬剤等設定情報を図2の「ポンプ側再入力薬剤等設定情報77a」として「ポンプ側再入力薬剤等設定情報記憶部77」に記憶させる。輸液ポンプ70bも同様に処理する。 If it is determined in ST16 that the input has been made again, the process proceeds to ST17. In ST17, the “medicine etc. setting information re-input determination unit (program) 76” in FIG. 2 operates, and the re-input medicine etc. setting information is set as “pump side re-input medicine etc. setting information 77a” in FIG. It is stored in the side re-input medicine etc. setting information storage section 77 ”. The infusion pump 70b is similarly processed.

 次いで、ST18へ進む。ST18では、輸液ポンプ70a、70bは、「ポンプ側再入力薬剤等設定情報記憶部77」の「ポンプ側再入力薬剤等設定情報77a」をラック装置10へ送信する。 Next, proceed to ST18. In ST18, the infusion pumps 70a and 70b transmit “pump-side re-input medicine setting information 77a” in the “pump-side re-input medicine setting information storage unit 77” to the rack device 10.

 次いで、ST19へ進む。ST19では、ラック装置10は、各輸液ポンプ70a、70bから受信した「ポンプ側再入力薬剤等設定情報77a」を当該ラック番号(R001)と関連付けて、図3の「ラック側再入力薬剤等設定情報21a」として「ラック側再入力薬剤等設定情報記憶部21」に記憶される。 Next, proceed to ST19. In ST19, the rack apparatus 10 associates the “pump-side re-entry medicine setting information 77a” received from each of the infusion pumps 70a and 70b with the rack number (R001), and sets the “rack-side re-entry medicine etc. setting” of FIG. Information 21a ”is stored in the“ rack-side re-input medicine setting information storage unit 21 ”.

 次いで、ST20へ進む。ST20では、ラック装置10が「ラック側再入力薬剤等設定情報21a」に「連携動作」情報が存在するか否かを判断する。すなわち、複数の輸液ポンプ70a等を用いた薬剤の同時又は連続の投与情報が存在するか否かを判断する。 Next, proceed to ST20. In ST20, the rack apparatus 10 determines whether or not “cooperation operation” information exists in the “rack-side re-input medicine etc. setting information 21a”. That is, it is determined whether there is information on simultaneous or continuous administration of drugs using a plurality of infusion pumps 70a and the like.

 ST20で、「ラック側再入力薬剤等設定情報21a」に「絶対的組合せ不可薬剤情報」又は「相対的組合せ不可薬剤情報」に該当する「連携動作」情報が存在しないと判断されたときは、再入力により薬剤の入力が変更され、新しい再入力の複数の薬剤については、同時又は連続投与があっても、組合せ投与による危険性がないと判断され、ST21へ進む。 When it is determined in ST20 that the “rack side re-entry medicine setting information 21a” does not include “cooperation operation” information corresponding to “absolute combination impossible drug information” or “relative combination impossible drug information”, The input of the medicine is changed by the re-input, and it is determined that there is no risk due to the combined administration even if there are simultaneous or continuous administration for a plurality of new re-input drugs, and the process proceeds to ST21.

 ST21では、ラック装置10が輸液ポンプ70a、70bに対して、それらの動作開始情報(輸液開始)を送信し、輸液ポンプ70a、70bが動作開始し、患者に対する送液が開始される。 In ST21, the rack apparatus 10 transmits the operation start information (infusion start) to the infusion pumps 70a and 70b, the infusion pumps 70a and 70b start to operate, and the infusion to the patient is started.

 一方、ST20で、「ラック側再入力薬剤等設定情報21a」に「絶対的組合せ不可薬剤情報」又は「相対的組合せ不可薬剤情報」に該当する「連携動作」情報が存在する場合は、ST22へ進む。ST22では、ラック装置10が管理サーバ30に「ラック側再入力薬剤等設定情報21a」を送信する。 On the other hand, in ST20, if “link operation information” corresponding to “absolute combination impossible drug information” or “relative combination impossible drug information” exists in “rack-side re-entry drug etc. setting information 21a”, go to ST22. move on. In ST <b> 22, the rack device 10 transmits “rack-side re-input medicine setting information 21 a” to the management server 30.

 次いで、図10のST23へ進む。ST23では、管理サーバ30が、受信した「ラック側再入力薬剤等設定情報21a」を「サーバ側再入力薬剤等設定情報」として、図6の「サーバ側再入力薬剤等設定情報記憶部51」に記憶する。 Next, the process proceeds to ST23 in FIG. In ST23, the management server 30 sets the received “rack-side re-entry medicine etc. setting information 21a” as “server-side re-entry medicine etc. setting information” and “the server-side re-entry medicine etc. setting information storage unit 51” in FIG. To remember.

 次いで、ST24へ進む。ST24では、図6の管理サーバ30の「薬剤等設定情報同一性判断部(プログラム)52」が動作し、「サーバ側再入力薬剤等設定情報記憶部51」の「サーバ側再入力薬剤等設定情報」を、図5の「サーバ側薬剤等設定情報記憶部41」の「サーバ側薬剤等設定情報」と比較する。 Next, proceed to ST24. In ST24, the “medicine etc. setting information identity determination unit (program) 52” of the management server 30 of FIG. 6 operates, and the “server side reentry medicine etc. setting information storage unit 51” “server side reentry medicine etc. setting” The “information” is compared with “server-side medicine setting information” in the “server-side medicine setting information storage unit 41” in FIG.

 次いで、ST25へ進む。ST25では、図6の「薬剤等設定情報同一性判断部(プログラム)52」が動作し、「サーバ側再入力薬剤等設定情報」は「サーバ側薬剤等設定情報」と同一か否かが判断される。
 すなわち、看護師等の利用者が輸液ポンプ70a等の再入力画面で、薬剤の設定等の情報(送液する薬剤名や他の連携する輸液ポンプ80b等の情報)を変更したか否かを判断する。
Next, the process proceeds to ST25. In ST25, the “medicine etc. setting information identity determination unit (program) 52” of FIG. 6 operates to judge whether “server side re-entry medicine etc. setting information” is the same as “server side medicine etc. setting information”. Is done.
That is, whether or not a user such as a nurse has changed information such as a medicine setting (information on a medicine to be delivered and other linked infusion pump 80b etc.) on the re-input screen of the infusion pump 70a or the like. to decide.

 ST25で、「サーバ側再入力薬剤等設定情報」は「サーバ側薬剤等設定情報」と同一でないと判断されたときは、入力内容の変更があったとして、ST26へ進む。
 ST26では、管理サーバ30が、「サーバ側再入力薬剤等設定情報記憶部51」の「サーバ側再入力薬剤等設定情報」と、図5の「組合せ不可薬剤情報記憶部43」の「組合せ不可薬剤情報43a」とを参照し、「絶対的組合せ薬剤情報」又は「相対的薬剤組合せ情報」に該当する「連携動作」情報が存在するか否かを判断する。
If it is determined in ST25 that “server-side re-entry medicine setting information” is not the same as “server-side medicine etc. setting information”, it is determined that the input content has been changed and the process proceeds to ST26.
In ST26, the management server 30 sets “server-side re-entry medicine setting information storage unit 51” “server-side re-entry medicine etc. setting information” and “combination impossible drug information storage unit 43” “combination impossible” in FIG. With reference to “drug information 43a”, it is determined whether or not “cooperative operation” information corresponding to “absolute combination drug information” or “relative drug combination information” exists.

 そして、その後、図8のST10以下と同様の工程が実行される。これらについては内容が重複するので、説明を省略する。 Then, the same process as ST10 and the subsequent steps in FIG. 8 is executed. Since these contents are duplicated, description thereof is omitted.

 一方、ST25で、「サーバ側再入力薬剤等設定情報」が「サーバ側薬剤等設定情報」と同一であると判断したときは、ST27へ進む。
 すなわち、この場合は、看護師等の利用者が、再入力画面で入力情報を変更しない場合である。
 本実施の形態では、再入力画面でも内容が変更されない例である。
On the other hand, if it is determined in ST25 that “server side re-entry medicine setting information” is the same as “server side medicine etc. setting information”, the process proceeds to ST27.
That is, in this case, a user such as a nurse does not change the input information on the re-input screen.
In this embodiment, the content is not changed even on the re-input screen.

 ST27では、図6の「絶対的組合せ不可薬剤情報判断部(プログラム)53」が動作し、当該「サーバ側再入力薬剤等設定情報」が「絶対的組合せ不可薬剤情報」に該当するか否かを判断する。
 すなわち、本実施の形態のように、看護師等の再入力の情報が変更されないということは、敢えて当該薬剤A及び薬剤Bとの組合せ(連携)を実行する医師の判断があったとして、当該情報が、薬剤の組合せである同時や連続投与等が絶対的に回避すべきであり、禁止される「絶対的組合せ不可薬剤情報」に該当するか否かを判断する。
In ST27, the “absolute combination impossible drug information determination unit (program) 53” of FIG. 6 operates, and whether or not the “server side re-entry drug setting information” corresponds to “absolute combination impossible drug information”. Judging.
That is, as in the present embodiment, the fact that the re-input information such as the nurse is not changed means that the doctor who dares to execute the combination (cooperation) with the medicine A and the medicine B It is determined whether the information corresponds to “absolute combination impossible drug information” for which simultaneous or continuous administration, which is a combination of drugs, should be avoided absolutely.

 ST27で、当該「サーバ側再入力薬剤等設定情報」が「絶対的組合せ不可薬剤情報」に該当する場合は、当該薬剤の連携は危険であると判断して、ST28へ進む。
 ST28では、「サーバ側再入力薬剤等設定情報」を図5の「組合せ不可薬剤該当情報」として「組合せ不可薬剤該当情報記憶部44」に記憶させる。
 その後、図8のST13以下の工程が実行され、輸液ポンプ70a等の輸液ポンプ側ディスプレイ71に薬剤情報等の再入力等が促される。
 したがって、「絶対的組合せ不可薬剤情報」に該当する薬剤の連携等の実行を未然に防ぐことができる構成となっている。
In ST27, if the “server-side re-input drug etc. setting information” corresponds to “absolute combination impossible drug information”, it is determined that the cooperation of the drugs is dangerous, and the process proceeds to ST28.
In ST28, the “server-side re-input medicine etc. setting information” is stored in the “uncombinable drug applicable information storage unit 44” as “uncombinable drug applicable information” in FIG.
Thereafter, the processes after ST13 in FIG. 8 are executed, and re-input of drug information or the like is prompted to the infusion pump-side display 71 such as the infusion pump 70a.
Therefore, it is possible to prevent the execution of cooperation of medicines corresponding to “absolute combination impossible medicine information”.

 一方、ST27で、当該「サーバ側再入力薬剤等設定情報」が「絶対的組合せ不可薬剤情報」に該当しない場合は、薬剤の組合せが一般的に可能であれば回避すべきである「相対的組合せ不可薬剤情報」であると判断し、再入力は、特段の理由があるとして、ST29へ進む。
 ST28では、管理サーバ30がラック装置10を介して、輸液ポンプ70a、70bに対して、それらの動作開始情報(輸液開始)を送信し、輸液ポンプ70a、70bが動作開始し、患者に対する送液が開始される。
On the other hand, if the “server-side re-entry drug setting information” does not correspond to “absolute combination impossible drug information” in ST27, it should be avoided if a combination of drugs is generally possible. It is determined that the information is “uncombinable drug information”, and re-entry proceeds to ST29 because there is a special reason.
In ST28, the management server 30 transmits the operation start information (infusion start) to the infusion pumps 70a and 70b via the rack device 10, and the infusion pumps 70a and 70b start to operate, and the infusion fluid to the patient. Is started.

 このように、本実施の形態では、「相対的組合せ不可薬剤情報」は、場合によっては、組合せ投与が認められる情報であるので、再入力で、同一の情報を入力し、それが、「相対的組合せ不可薬剤情報」に該当するときは、看護師等の利用の便宜等を考慮し、その入力通りの薬剤の送液を認める構成となっている。 As described above, in the present embodiment, the “relative combination impossible drug information” is information in which combination administration is permitted in some cases, and therefore, the same information is input by re-input. In the case of “combinable drug information that cannot be combined”, in consideration of the convenience of use by nurses and the like, it is configured to permit the delivery of medicine as input.

 ところで、本発明は、上述の実施の形態に限定されない。本実施の形態では、医療機器として輸液ポンプ70a等を例に説明したが、本発明は、これに限らず、シリンジポンプ等の他の医療機器等でも好適に適用することができる。
 また、本実施の形態では、「組合せ不可薬剤情報43a」に該当するか否か等は、ラック装置10を介して管理サーバ30で実行されているが、本発明では、これに限らず、輸液ポンプ70aやラック装置10等で、かかる判断等を行っても構わない。
 また、本実施の形態では、「組合せ不可薬剤情報記憶部43」内の「組合せ不可薬剤情報43a」の編集については深く言及していないが、通常、病院ごとに組合せ不可能とする薬剤情報等を看護師等が手入力でデータベース化することになる。しかし、これに限らず、例えば、日本医師会が提供する「日医医薬品併用禁忌データベース」から組合せ不可能とする薬剤情報を「組合せ不可薬剤情報記憶部43」内に取り込みデータベース化しても構わなく、さらにそのデータベースを病院ごとに編集することでも良い。すなわち、「組合せ不可薬剤情報記憶部43」」内の「組合せ不可薬剤情報43a」の編集については看護師等の手入力だけでなく、外部との通信により「組合せ不可薬剤情報43a」の取得が可能である。
By the way, the present invention is not limited to the above-described embodiment. In the present embodiment, the infusion pump 70a and the like have been described as an example of the medical device, but the present invention is not limited to this, and can be suitably applied to other medical devices such as a syringe pump.
Further, in the present embodiment, whether or not it corresponds to “uncombinable drug information 43a” or the like is executed by the management server 30 via the rack device 10, but the present invention is not limited to this and is not limited to this. Such a determination may be made by the pump 70a, the rack device 10, or the like.
In the present embodiment, the editing of “uncombinable drug information 43a” in the “uncombinable drug information storage unit 43” is not referred to deeply. A nurse or the like will create a database manually. However, the present invention is not limited to this. For example, drug information that cannot be combined from the “Nichi medicine combination contraindication database” provided by the Japan Medical Association may be incorporated into the “non-combination drug information storage unit 43” and converted into a database. Furthermore, the database may be edited for each hospital. In other words, the editing of the “uncombinable drug information 43a” in the “uncombinable drug information storage unit 43” is not limited to manual input by a nurse or the like, but the “uncombinable drug information 43a” is acquired by communication with the outside. Is possible.

 1・・・薬剤組合せ管理システム、10・・・ラック装置、11・・・ラック本体、12・・・第1装着部、13・・・第2装着部、14・・・第3装着部、15・・・通信ボックス、16・・・ラック制御部、17・・・ラック側ディスプレイ、18・・・ラック側通信装置、19・・・ラック側薬剤等設定情報記憶部、19a・・・ラック側薬剤等設定情報、20・・・ポンプ連携動作情報有無判断処理部(プログラム)、21・・・ラック側再入力薬剤等設定情報記憶部、21a・・・ラック側再入力薬剤等設定情報、30・・・管理サーバ、31・・・サーバ制御部、32・・・サーバ側入力装置、33・・・サーバ側ディスプレイ、34・・・サーバ側通信装置、40・・・第1各種記憶部、41・・・サーバ側薬剤等設定情報記憶部、42・・・組合せ不可情報判断処理部(プログラム)、43・・・組合せ不可薬剤情報記憶部、43a・・・組合せ不可薬剤情報、44・・・組合せ不可薬剤該当情報記憶部、50・・・第2各種情報記憶部、51・・・サーバ側再入力薬剤等設定情報記憶部、52・・・薬剤等設定情報同一性判断部(プログラム)、53・・・絶対的組合せ不可薬剤情報判断部(プログラム)、70a、70b・・・輸液ポンプ、71・・・輸液ポンプ側ディスプレイ、72・・・輸液ポンプ側入力装置、73・・・輸液ポンプ制御部、74・・・輸液ポンプ側通信装置、75・・・ポンプ側薬剤等設定情報記憶部、75a・・・ポンプ側薬剤等設定情報、76・・・薬剤等設定情報再入力判断部(プログラム)、77・・・ポンプ側再入力薬剤等設定情報記憶部、77a・・・ポンプ側再入力薬剤等設定情報 DESCRIPTION OF SYMBOLS 1 ... Drug combination management system, 10 ... Rack apparatus, 11 ... Rack main body, 12 ... 1st mounting part, 13 ... 2nd mounting part, 14 ... 3rd mounting part, DESCRIPTION OF SYMBOLS 15 ... Communication box, 16 ... Rack control part, 17 ... Rack side display, 18 ... Rack side communication apparatus, 19 ... Rack side chemical | medical agent setting information storage part, 19a ... Rack Side drug etc. setting information, 20... Pump cooperation operation information presence / absence judgment processing unit (program), 21... Rack side re-input medicine etc. setting information storage unit, 21 a. DESCRIPTION OF SYMBOLS 30 ... Management server, 31 ... Server control part, 32 ... Server side input device, 33 ... Server side display, 34 ... Server side communication apparatus, 40 ... 1st various memory | storage part , 41... Server side medicine setting information Memory unit 42... Combination impossible information determination processing unit (program) 43... Combination impossible drug information storage unit 43 a... Combination impossible drug information 44. ... 2nd various information storage part, 51 ... Server side re-entry medicine etc. setting information storage part, 52 ... Medicine etc. setting information identity judgment part (program), 53 ... Absolute combination impossible medicine Information judging unit (program), 70a, 70b ... infusion pump, 71 ... infusion pump side display, 72 ... infusion pump side input device, 73 ... infusion pump control unit, 74 ... infusion pump Side communication device, 75... Pump side medicine setting information storage section, 75 a... Pump side medicine setting information, 76... Medicine setting information re-input determination section (program), 77. Re-entry drug Setting information storage unit, 77a · · · pump side reenter agents such setting information

Claims (4)

 複数の医療機器を用いて、対象者に投与される複数の薬剤情報の組合せ投与情報の適否を判断し、当該複数の薬剤情報の組合せ投与情報が不適であるときは、当該薬剤組合せ不適情報を提供し、利用者に前記複数の薬剤情報の組合せ投与情報の再入力を求める構成となっていることを特徴とする医療情報管理システム。 Using a plurality of medical devices, the suitability of combination administration information of a plurality of drug information to be administered to a subject is judged, and when the combination administration information of the plurality of drug information is inappropriate, the drug combination inappropriate information is A medical information management system, characterized in that the system is configured to prompt a user to re-input combination administration information of the plurality of pieces of drug information.  前記薬剤組合せ不適情報は、絶対的組合せ不可薬剤情報と相対的組合せ不可薬剤情報を含み、
 前記薬剤組合せ不適情報として、前記相対的組合せ不可薬剤情報を利用者に提供した後、利用者が、同一の前記複数の薬剤情報の組合せ投与情報を再入力したときは、再び前記薬剤組合せ不適情報を提供しない構成となっていることを特徴とする請求項1に記載の医療情報管理システム。
The drug combination inadequate information includes absolute combination impossible drug information and relative combination impossible drug information,
When the user re-enters combination administration information of the same plurality of pieces of drug information after providing the relative combination impossible drug information to the user as the drug combination inappropriate information, the drug combination inappropriate information again. The medical information management system according to claim 1, wherein the medical information management system is configured to provide no information.
 前記複数の医療機器は、ラック部に配置され、このラック部は医療情報管理装置と通信可能な構成とされ、
 前記医療情報管理装置は、前記複数の薬剤情報の組合せ投与情報を前記ラック部から取得して、この取得した複数の薬剤情報の組合せ投与情報に基づき、その適否を判断し、不適であるときは、前記薬剤組合せ不適情報を生成する構成となっていることを特徴とする請求項1又は請求項2に記載の医療情報管理システム。
The plurality of medical devices are arranged in a rack part, and the rack part is configured to be communicable with a medical information management device,
The medical information management device acquires combination administration information of the plurality of pieces of drug information from the rack unit, determines suitability based on the acquired combination administration information of the plurality of pieces of drug information, and when it is inappropriate The medical information management system according to claim 1, wherein the medical combination inappropriate information is generated.
 複数の医療機器を用いて、対象者に投与される複数の薬剤情報の組合せ投与情報の適否を判断し、当該複数の薬剤情報の組合せ投与情報が不適であるときは、当該薬剤組合せ不適情報を提供し、利用者に前記複数の薬剤情報の組合せ投与情報の再入力を求める構成となっていることを特徴とする医療情報管理方法。 Using a plurality of medical devices, the suitability of combination administration information of a plurality of drug information to be administered to a subject is judged, and when the combination administration information of the plurality of drug information is inappropriate, the drug combination inappropriate information is A medical information management method, characterized in that it is configured to prompt a user to re-input combination administration information of the plurality of pieces of drug information.
PCT/JP2013/059996 2013-04-01 2013-04-01 Medical-information management system and medical-information management method Ceased WO2014162485A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/JP2013/059996 WO2014162485A1 (en) 2013-04-01 2013-04-01 Medical-information management system and medical-information management method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/JP2013/059996 WO2014162485A1 (en) 2013-04-01 2013-04-01 Medical-information management system and medical-information management method

Publications (1)

Publication Number Publication Date
WO2014162485A1 true WO2014162485A1 (en) 2014-10-09

Family

ID=51657818

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2013/059996 Ceased WO2014162485A1 (en) 2013-04-01 2013-04-01 Medical-information management system and medical-information management method

Country Status (1)

Country Link
WO (1) WO2014162485A1 (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006521191A (en) * 2003-03-28 2006-09-21 カーディナル ヘルス 303、インコーポレイテッド Infusion data communication system
JP2007117572A (en) * 2005-10-31 2007-05-17 Toshiba Corp Drug administration system and drug preparation device
JP2012003415A (en) * 2010-06-15 2012-01-05 Panasonic Corp Prescription checking system and prescription checking method

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006521191A (en) * 2003-03-28 2006-09-21 カーディナル ヘルス 303、インコーポレイテッド Infusion data communication system
JP2007117572A (en) * 2005-10-31 2007-05-17 Toshiba Corp Drug administration system and drug preparation device
JP2012003415A (en) * 2010-06-15 2012-01-05 Panasonic Corp Prescription checking system and prescription checking method

Similar Documents

Publication Publication Date Title
TWI879840B (en) Infusion pump with safety sequence keypad
US8768719B2 (en) Medication administration and management system and method
US9526825B2 (en) Multiple drug infusion system and method
JP5864661B2 (en) Medical pump programming using electronic standing order templates
US20230112979A1 (en) Infusion pump with alarm manager
CN104602727B (en) The control method of equipment loading device and equipment loading device
JP2021121332A (en) Patient treatment device specific configuration output
JP6698071B2 (en) Liquid transfer pump management system
JP5851512B2 (en) Drug information management apparatus and drug information management method
WO2014162485A1 (en) Medical-information management system and medical-information management method
US20240216604A1 (en) Pca pump programming and patient history user interface
WO2013128886A1 (en) Fluidic pump and network system
WO2014162487A1 (en) Medical-information management device, medical-information management system, and method for controlling medical-information management device
Bain The Cellnovo insulin delivery system
US20260014312A1 (en) User interface for pca pump programming to prevent dose errors
US20230129139A1 (en) System and method for providing a medication at a medical device
CN121237357A (en) Fusion display method and display system for medical information
WO2014162486A1 (en) Medical-information management device and medical-information management method
WO2014049658A1 (en) Fluid delivery device, fluid delivery system, and control method for fluid delivery device
KR20210074051A (en) System for assisting a medical order input

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 13881250

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 13881250

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: JP